SavedAdd your journal

Journals / Ege Pediatri Bülteni / 2006 / Cilt: 13 - Sayı: 3

Intratracheal N-acetyl cysteine lavage in neonates with pulmonary atelectasis

Pulmoner atelektazili yenidoğan bebeklerde intratrakeal N-asetil sistein lavajı

Aslıhan KARA
Hasan ÇETİN
Ayça Esra AKKAYA
Pages
163–167
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Intratracheal N-acetyl cysteine lavage may be alternative treatment in severe and recurrent pulmonary atelectasis in neonatal intensive care unit.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pulmonary atelectasis is not uncommon, but an important problem in neonatal intensive care unit.
📊
Key Findings & Data:In the present study we demonstrated the successfuly use of intratracheal N-acetyl cysteine lavage in two newborn infants.
💡
Conclusion & Impact:Intratracheal N-acetyl cysteine lavage may be alternative treatment in severe and recurrent pulmonary atelectasis in neonatal intensive care unit.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pulmonary atelectasis is not uncommon, but an important problem in neonatal intensive care unit. Respiratory distress syndrome, prematurity, neonatal or ventilator-associated pneumonia and mechanical ventilation are the main causes of pulmonary atelectasis. Supportive therapy may be insufficient for treatment of atelectasis. Use of recombinant human-DNase is very expensive and limited in newborn infants. In the present study we demonstrated the successfuly use of intratracheal N-acetyl cysteine lavage in two newborn infants. Intratracheal N-acetyl cysteine lavage may be alternative treatment in severe and recurrent pulmonary atelectasis in neonatal intensive care unit.

Özet

Yenidoğan yoğun bakım ünitesinde akciğer atelektazisi, önemli ve nadir olmayan bir sorundur. Respiratuvar distres sendromu, prematürelik, neonatal ya da ventilatör-ilişkili pnömoni ve mekanik ventilasyon akciğer atelektazisinin temel sebepleridir. Atelektazi tedavisinde destek tedavisi yetersiz olabilir. Yenidoğan bebeklerde rekombinan insan-DNaz kullanımı hem kısıtlı hem de çok pahalıdır. Bu çalışmada intratrakeal N-asetil sistein lavajı ile başarılı olarak tedavi edilen iki yenidoğan bebek sunulmuştur. Yenidoğan yoğun bakım ünitesinde, intratrakeal N-asetil sistein lavajı, ciddi ve tekrarlayan akciğer atelektazilerinin tedavisinde alternatif bir yöntem olabilir.

🔖

Cite This Article

KARA, A., ÇETİN, H., AKKAYA, A. E. (2022). Intratracheal N-acetyl cysteine lavage in neonates with pulmonary atelectasis. Ege Pediatri Bülteni, Cilt: 13 - Sayı: 3, 163–167. https://ajindex.com/articles/495735

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Küpeli S, Teksam O, Doğru D. and Yurdakök M. Use of recombinant human DNase in a premature infant with recurrent atelectasis. Pediatrics Int 2003; 45: 584-586
  2. Fuloria M, Rubin BK. Evaluating the efficacy of mucoactlve aerosol therapy. Respir Care 2000; 45: 868-873
  3. Majima Y. Mucoactive medications and airway disease. Paediatr Respir Rev 2002; 3: 104-109
  4. Kasielski M, Nowak D. Long-term administration of H-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med 2001; 95: 448-456
  5. Aruoma Ol. Halliwell B. Hoey BM, Beutler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochloric acid. Free Radic Biol Med 1989; 6(6): 593-597
  6. Peristeris P, Clark BD. Qatti S, Faggioni R, Mantovani A, Mengozzi M, et al. M-acetylcysteine and gluthathione as inhibitors of tumor necrosis factor production. Cell Immunol 1992; 140: 390-399
  7. Zhang H, Spapen H, Mguyen DM, Benlabed M, Buurman WA, Vincent JL. Protective effects of n-acetyl-L-cysteine in endotoxemia. Am J Physiol 1994; 266: 1746-1754
  8. Sen CK. Rankinen S. Vaisanen S. Rauramaa R. Oxidative stress after human exercise: effect of M-acetylcysteine supplementation. J Appl Physiol 1994; 76: 2570-2577
  9. Verhasselt V, Vanden Berghe W. Vanderheyde M. M-acetylcysteine inhibits primary human T cell responses at the dendritic cell level: association with MP-kB inhibition. J Immunol 1999; 162: 2569-2574. 10.Gallon AM. Evaluation of nebulised acetylcysteine and normal saline in the treatment of sputum retention following thoracotomy. Thorax 1996; 51(4): 429-324. 11.Bibi H. Seifert B. Oullette M. Bellk J. Intratracheal M-acetylcysteine use in inlants with chronic lung disease. Acta Paediatr 1992 Apr; 81(4): 335-339. 12.El Hassan MO. Chess PR. Huysman MW. Merkus PJ, de Jongste JC. Rescue use of DNase in critical lung atelectasis and mucus retention in premature neonates. Pediatrics 2001 Aug; 108(2): 468-470.